Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor
In Reply.—Dr Hsu agreed with my call for making conflict of interest policies as clear and explicit as possible. I am grateful that he pointed out that patients are also important stakeholders in this process. The University of California, San Francisco, Chancellor's Committee on Relations With Industry, which I described in my Editorial, has 2 members from the lay community. Mr Trevett reinforces the point made in my Editorial that gifts should be subjected to the same scrutiny as research grants, particularly when legal arrangements regarding technology transfer are involved.
Bero LA. Corporate Gifts to Academic Researchers—Reply. JAMA. 1998;280(10):883-884. doi:10-1001/pubs.JAMA-ISSN-0098-7484-280-10-jac80015